Immuneering Corporation

Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. Immuneering has more than a decade of experience in translational bioinformatics and generating insights into drug mechanisms of action and patient treatment responses. Building on this experience, Immuneering has developed a disease-agnostic platform that enables the company to utilize human data, novel biology and chemistry, and translational planning to create and advance its wholly owned pipeline. Immuneerings current development programs in...

Computational biology,genomics,drug developement,neurodegenerative disease,and oncology

Immuneering corporation operates in the Biotechnology industry.

Immuneering corporation's revenue is 11m - 100m

Immuneering corporation has 51 - 200 employees.